Transplanted bone marrow endothelial progenitor cells delay ALS disease progression
Wednesday, April 3, 2019 - 09:00
in Health & Medicine
Transplanting human bone marrow-derived endothelial progenitor cells into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier, researchers report. The new research contributes to a growing body of work exploring cell therapy approaches to barrier repair in ALS and other neurodegenerative diseases.